Stigma and shame associated with sexually transmitted diseases (STDs) and HIV infection are important barriers to appropriate diagnos tic and treatment services. For example, in one study, 59% of men who had never been tested for HIV cited fear of negative social consequences as an important reason for not seeking testing. 1 Stigma may influence preg nant women's refusal to be tested for HIV de spite the benefits of treatment during pregnancy. 2, 3 Similarly, 44% of the high-risk males in a study by Woods et al. stated that if name-based reporting were implemented, they would not accept HIV testing, and they maintained this intention even after being told of the potential benefits of such reporting. 4 A recent Institute of Medicine report identified stigma as a key element of the "hid den epidemic" of STDs in the United States. 5 Stigma and shame are related but distinct constructs. Stigma is defined as an attribute or label that sets a person apart from others and links the labeled person to undesirable characteristics. 6 Stigma related to AIDS has been defined as "the prejudice, discounting, dis crediting, and discrimination that are directed at people perceived to have AIDS." 7 An additional implicit characteristic of stigma is that it represents socially shared knowledge understood even by the targets of the stigmatizing attitudes and behaviors. 8 Thus, shame can be an internalized reaction to stigma. 6, 9 Shame is defined as a negative emotion elicited when a person experiences failure in relation to personal or social stan dards, feels responsible for this failure, and be lieves that the failure reflects self-inadequacy rather than inappropriate behavior. The term "self-stigmatization" is sometimes used synony mously with shame to reflect a person's ac ceptance of the negative aspects of a stigma. 7 Shame is clearly distinguishable, however, from the related negative affect states of guilt and embarrassment. 10 Objectives. The purpose of this study was to assess the relationships between stigma and shame as sociated with seeking treatment for sexually transmitted diseases (STDs) and undergoing testing for gon
Methods.
scales assessed STD-related stigma and STD-related shame.
Results. Participants were 847 males and 1126 females (mean age: 24.9 years) in 7 cities. Two
Conclusions
Rates of stigma and shame were higher among participants without a gonorrhea test in the past year and among those without an HIV test. Sex, age, health service use, previous suspicion of gon orrhea, and low levels of stigma were independently associated with gonorrhea testing. Age, enrollment site, use of health services, gonorrhea testing, and low levels of stigma were independently associated with HIV testing.
Shame is part of the experience of seeking STD-related care, but stigma may be a more
The purpose of this research was to exam ine relationships of stigma and shame with 2 types of STD-related care: receipt of a test for gonorrhea during the past year and receipt of at least 1 HIV test in the previous year. Re ceipt of gonorrhea or HIV screening requires care seeking by individuals and communica tion with clinicians that may be affected by stigma, shame, or both. In the case of both gonorrhea and HIV, screening provides an opportunity for risk-reduction interventions among those who are not infected. Among those found to be infected, effective treatment and control strategies can reduce the risk of sequelae and limit transmission to others. 11, 12 STD/HIV-related care could therefore be im proved through a better understanding of fac tors such as stigma or shame that may act as barriers to appropriate screening.
METHODS

Respondents
Data were collected in 1998 as part of the Gonorrhea Community Action Project, a multisite research program designed to evalu ate STD-related care from the multiple per spectives of clients, providers, and health care systems. Participating sites included Prince George's County, Maryland; Denver, Colo; Los Angeles, Calif; Indianapolis, Ind; St. Louis, Mo; Central Harlem, NY; and Birmingham, Ala.
Respondents were recruited from clinics, from community-based organizations, and through street intercept in each of the 7 lo cations. Clinic sites were mainly primary care settings but also included STD clinics. The street intercept and community-based organization recruitment strategies targeted constituencies at high risk for gonorrhea and HIV. Administrators at each research site were asked to interview an equal number of subjects from each recruitment source. All information was collected via face-to-face in terviews requiring 20 to 40 minutes to com plete. No effort was made to match inter viewers and respondents in regard to sex, race/ethnicity, age, or sexual preference.
The study protocol was approved by the in stitutional review boards of the participating sites as well as the institutional review board of the Centers for Disease Control and Pre vention. Written informed consent was ob tained from each participant.
Measures
Two dependent variables were chosen: gonorrhea testing and HIV testing. Respon Getting a sexually transmitted disease means I have poor morals dents were asked, "In the past 12 months, how often have you been to a doctor, hospi tal, or clinic to get tested for gonorrhea?" A similarly phrased question assessed HIV test ing in the past year. Responses to each item were recoded to represent either "no test in the previous year" or "any (gonorrhea or HIV) test in the previous year." STD-related stigma and STD-related shame were measured via items developed for the current research. A larger set of items was de veloped to assess personal reactions to STD and STD-related testing as well as perceptions of others' responses to these issues. Partici pants responded on a 5-point Likert scale ranging from strongly disagree to strongly agree. Pilot tests involving 100 volunteers were conducted to assess factor structure and scale reliability. Items that had factor loadings (i.e., correlations with their underlying factor) of .50 and contributed to overall scale relia bility were retained. All factor cross loadings (i.e., correlations with nonunderlying factors) were less than .50. STD-related stigma (5 items; α = .77) reflected the participant's ex pectation of isolation and adverse social judg ment associated with STD. STD-related shame (6 items; α = .80) reflected the participant's sense of shame and contamination associated with STD (Table 1) .
Items in each scale were summed to create scale scores, with higher scores reflecting greater stigma or shame. The stigma and shame scales were moderately correlated (r = 0.54), suggesting that they measured separate Getting examined for a sexually transmitted disease means I'm not clean but related constructs. Scale scores below the 75th percentile were reclassified as "low," and scores above the 75th percentile were re classified as "high."
Additional predictor measures included sex, age (14-19, 20-29, 30-39, 40-49, or 50-59 years), enrollment site (community/ health care facility), health service use in the past year (no/yes), and suspicion of gonor rhea in the past year (no/yes). These vari ables were selected to control for potential demographic differences in STD-related care seeking as well as influences of general use of health care or STD-related symptoms. With 2 exceptions, similar models were evaluated for each outcome. For gonorrhea testing, previ ous suspicion of gonorrhea was included to control for symptom-motivated care seeking. For HIV testing, receipt of a gonorrhea test in the past year was entered to control for rou tine HIV testing associated with STD-related visits.
Logistic regression (with 95% confidence intervals for each odds ratio) was used in con ducting statistical analyses. Predictors were entered in a single block. Level of statistical significance was set at P < .05.
RESULTS
The original sample included 2020 indi viduals aged 12 to 83 years. Data on sex or age were missing for 10 participants, and these individuals were excluded from subse quent analyses. In addition, we restricted the (Table 2) . Missing data reduced the available sample for some analyses. The majority of participants of both sexes were younger than 39 years. Sixty percent of the participants were enrolled from health care facilities.
There were no differences between male and female participants in regard to age or enrollment location (Table 2 ). Males were more likely than females to have suspected gonorrhea in the past, but females were more likely than males to have received a gonor rhea or HIV test in the past year. A signifi cantly higher proportion of males were classi fied in the "high shame" group.
Multiple logistic regression analysis showed that gonorrhea testing was independently re lated to female sex, younger age, enrollment from a health facility, health service use in the past year, suspicion of gonorrhea, and low levels of STD-related stigma (Table 3) . HIV testing was related to older age, health service use, gonorrhea testing, and low levels of STDrelated stigma. STD-related shame was not re lated to gonorrhea testing or HIV testing.
DISCUSSION
We found that STD-related stigma was as sociated with a decreased likelihood of being tested for gonorrhea or HIV during the past year. This association was independent of other factors that may affect testing, such as sex, age, and suspicion of gonorrhea. STDrelated shame was not associated with receipt of STD-related care. This is not to say that negative emotions associated with STD/HIVrelated care are an unimportant element of people's health care experiences. 13 Rather, the perception that others confer negative attrib utes to those with STD is associated with less than optimal STD/HIV-related care. Our findings are consistent with widely held assumptions about the role of stigma as a barrier to STD-related care. Our finding that stigma, rather than shame, may be a bar rier to STD-related care seeking highlights the potential difficulties facing interventions de signed to improve STD-related care seeking. Increasing knowledge or health care access may not address the barriers posed by STD- 281 (33) 445 (40) 320 (38) 402 (36) 167 (20) 205 (18) 60 (7) 57 (5) 19 (2) 17 (2) 541 (65) 820 (74) 291 (35) 290 (26) 344 (41) 448 (40) 500 (59) 675 (60) 422 (50) 433 (39) 424 (50) 693 (61) 322 (39) 383 (35) 497 (61) 714 (65) 621 (73) 852 (76) 226 (27) 274 (24) 546 ( 14 Lay health advisors have been suggested as an excellent means for promotion of com munity norms of healthy sexuality and STDrelated care. 15 However, a substantial body of social psychological research demonstrates the resistance to change of social stereotypes, especially in regard to conditions judged to be associated with irresponsible behavior. 16 As long as at-risk people perceive adverse judgments associated with STD, stigma is likely to remain an important barrier to ap propriate care. related stigma. 4 Communitywide intervenpected to achieve some gains, although the tions, advocacy, and education might be ex-(not uncommon) opinion that acknowledg- 
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